Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for myeloid lymphoid leukemia protein (compound)
Most Correlated Studies
- Acute myeloid leukemia cells treated with cell-specific IC50 concentrations of etoposide
- Acute leukemia cells treated with cell-permeable chemical degrader of TRIM24
- Leukemia K-562, MOLM13 and MV-4-11 cells treated with imatinib or AC220 compound
- Gene expression profiling of CEBPA double and single mutant and CEBPA WT AML
- Acute myeloid leukemia primary cells and cell lines treated with Iressa
Most Relevant Literature
- Discovery of novel pyrrolo[2,3-d]pyrimidines as potent menin-mixed lineage leukemia interaction inhi…
- Acute myeloid leukaemia (AML) with KMT2A rearrangement presented with haemophagocytic lymphohistiocy…
- Fusion transcripts are present in early progenitor cells in KMT2A-rearranged B-ALL.
- KMT2A amplification in B lymphoblastic leukaemia.
- A novel KMT2A::DCP1B rearrangement in chronic neutrophilic leukemia.
Most Relevant Clinical Trials
- Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphobl…
- EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refr…
- Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia,…
- Dasatinib or Nilotinib Followed by Imatinib in Patients With Newly Diagnosed, Chronic Phase Chronic …
- Omacetaxine and Venetoclax for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Mye…
